The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Open accessAbstract
Point mutations of the NADP + -dependent isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) occur early in the pathogenesis of gliomas. When mutated, IDH1 and IDH2 gain the ability to produce the metabolite ( R )-2-hydroxyglutarate (2HG), but the downstream effects of mutant IDH1 and IDH2 proteins or of 2HG on cellular metabolism are unknown. We profiled >200 metabolites in human oligodendroglioma (HOG) cells to determine the effects of expression of IDH1 and IDH2 mutants. Levels of amino acids, glutathione metabolites, choline derivatives, and tricarboxylic acid (TCA) cycle intermediates were altered in mutant IDH1- and IDH2-expressing cells. These changes were similar to those identified after treatment of the cells with 2HG. Remarkably, N -acetyl-aspartyl-glutamate (NAAG), a common dipeptide in brain, was 50-fold reduced in cells expressing IDH1 mutants and 8.3-fold reduced in cells expressing IDH2 mutants. NAAG also was significantly lower in human glioma tissues containing IDH mutations than in gliomas without such mutations. These metabolic changes provide clues to the pathogenesis of tumors associated with IDH gene mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a portion of the succinate that accumulates during ischemia and inflammation is released from the cell into the extracellular environment through poorly defined processes. This occurs following IR injury158,159, inflammation10, or cold exposure160.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [159]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,675
Chiang, L. H., Russell, E. L., & Braatz, R. D. (2001) · Advanced textbooks in control and signal processing · doi:10.1007/978-1-4471-0347-9_4 · Cited by 6,684
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Self-citationIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Self-citationCancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Cited by
Sorted by citations
Items 401–451 of 451
Environment-sensitive fluorescent probes targeting mutant IDH1 for in vivo glioma imaging
Li, W., Song, L., Lv, W., Xin, T., Sun, D., & Zhao, W. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345591 · Cited by 1
Mitochondrial permeability transition in redox homeostasis and ferroptosis
Guo, L. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113244 · Cited by 1
“The collapse of Δψ m and mitochondrial dysfunction prevents the conversion of NADH to NADPH by NADP + -dependent enzymes NNT, isocitrate dehydrogenase 2 and malic enzyme 3 (240, 241).”
Kundu, I. G., Toro, N., Mochizuki, A. Y., Langhnoja, J., Ayyagari, R. V., Cronk, J. C., Reel, S. M., Arounleut, P., Esqueda, L. T., Fuller, C. E., et al. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag228 · Cited by 1
Proteomic Studies in Low-Grade Gliomas: What Have They Informed About Pathophysiology?
Gerth, A. M. J., Deighton, R. F., McCulloch, J., & Whittle, I. R. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2213-5_9 · Cited by 1
MRS for D-2HG Detection in IDH-Mutant Glioma
Andronesi, O. C., Batchelor, T. T., & Cahill, D. P. (2019) · Springer eBooks · doi:10.1007/978-3-030-27359-0_11 · Cited by 1
The cAMP Inducers Modify N-Acetylaspartate Metabolism in Wistar Rat Brain
Kowalski, R. G., Pikuł, P., Lewandowski, K. C., Sakowicz‐Burkiewicz, M., Pawełczyk, T., & Zyśk, M. (2021) · Antioxidants · doi:10.3390/antiox10091404 · Cited by 1
“Other studies have shown that NAA and NAAG treatment triggers in vitro maturation of immature glia in in vitro cultures resulting in extensive astrocyte maturation [46].”
BackgroundPreclinical Experimental Models for Human Glioma
Zhang, D., Li, Y., Wang, Y., Jü, R., & Guo, L. (2023) · Human Brain · doi:10.37819/hb.4.1789
Gadde, U. D., Oh, S., Lillehoj, H. S., & Lillehoj, E. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-82285-2 · Cited by 1
RetractedHagland, H. R. (2012) · NORA - Norwegian Open Research Archives
Nitric oxide sensing and response in vibrio cholerae
Stern, A. M. (2014) · ScholarlyCommons (University of Pennsylvania)
Biomarker Discovery, Validation and Clinical Application for Patients Diagnosed with Glioma
Kerrie, L. (2011) · InTech eBooks · doi:10.5772/21765
The Role of Glutamine Synthetase in the Glutamine Independence in Mammary Tissue
Kung, H., & Chi, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1932-1_7
Research Highlights: Highlights from the Latest Articles in Metabolomic Studies of Cancer
Milburn, M. V. (2012) · Personalized Medicine · doi:10.2217/pme.12.93
Mapping Dysregulated Metabolic Pathways in Cancer Using Functional Metabolomic Platforms
Benjamin, D. I. (2015) · eScholarship (California Digital Library)
Palmitic Acid Activation of Dendritic Cells: Implications for Type 2 Diabetes
Nicholas, D. (2015) · The Scholars Repository - LLU (Loma Linda University)
Investigating Dysregulated Metabolic Pathways that Drive Cancer Pathogenicity
Roberts, L. S. (2017) · eScholarship (California Digital Library)
Impact of San-mediated Signaling on Glioblastoma and Neuroblastoma Metabolism
Silva, M. R. (2018) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc006885
Stuani, L., Sabatier, M., Millard, P., Palama, T., Poupin, N., Saland, E., Bosc, C., Tonini, L., Gales, L., Montersino, C., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3255557
The ketogenic diet is not effective in preclinical models of IDH1 wild-type and IDH1 mutant gliomaPreprint
Javier, R. A., & Horbinski, C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.23.166652
Magnetic Resonance for non-invasive evaluation of preclinical models of human brain tumors
Hamans, B. C. (2015) · Radboud Repository (Radboud University)
Mitochondrial DNA (mtDNA) and Cancer Pathogenesis – The Role of mtDNA Mutations: A Review
Chrysanthakopoulos, N. A. (2021) · doi:10.47733/gjccr.2020.2101
Pihlajaniemi, T. A. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14143956.15637056
Prchal, J. T. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14143956.15779475
Auld, D., Lea, W., Davis, M. I., & Simeonov, A. M. (2011) · Assay and Drug Development Technologies · doi:10.1089/adt.2011.0903.lr
Branzoli, F., Deelchand, D. K., Liserre, R., Poliani, P. L., Nichelli, L., Sanson, M., Lehéricy, S., & Marjańska, M. (2023) · Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · doi:10.58530/2022/0059
Duan, Y., Yu, J., Chen, M., Lu, Q., Ning, F., Gan, X., Liu, H., Ye, Y., Lu, S., & Lash, G. E. (2023) · Figshare · doi:10.6084/m9.figshare.22679503
Leucémies aigües myéloïdes avec mutations IDH1/2
Gabellier, L., Bosetta, E., Heiblig, M., & Sarry, J. (2025) · médecine/sciences · doi:10.1051/medsci/2025045
Ge, Y., Yu, M., Chang, T., Wang, Z., Zhang, Y., Chen, H., Chen, X., Li, X., Ji, N., & Shen, H. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03132-z
“…high-fi eld strength and advanced spectral editing techniques, coupled with a prospective cohort study design, holds signi fi cant importance for validating and further elucidating the role of 2HG in gene methylation, as well as exploring its potential clinical bene fi ts and therapeutic bene fi ts.”
Weidlich, A., Schaser, K.-D., Juratli, T. A., Pablik, J., Märdian, S., Hauptmann, K., Schwabe, P., Richter, S., & Fritzsche, H. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5374498
Jiang, A. Y. L., Yale, A. R., Hanamoto, J. N., Lav, N. S., Dang, V., Ro, C. C., Douglas, C., Di, K., Deyell, J., Bota, D. A., et al. (2025) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70069
“2,31,32 We cultivated these cells in serum-free conditions as used for patient-derived human glioma cells and refer to them as HOG-A to reflect the original name (HOG) and the updated classification as malignant astrocytoma (A).”
Epigenome in gliomas: novel targets for therapy
Ashesh, A. M., Lari, M. Q., Chaurasia, Y., Kumar, A., & Kumar, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33910-3.00006-6
Duan, Y., Yu, J., Chen, M., Lu, Q., Ning, F., Gan, X., Liu, H., Ye, Y., Lu, S., & Lash, G. E. (2023) · Figshare · doi:10.6084/m9.figshare.22679494
Duan, Y., Yu, J., Chen, M., Lu, Q., Ning, F., Gan, X., Liu, H., Ye, Y., Lu, S., & Lash, G. E. (2023) · Figshare · doi:10.6084/m9.figshare.22679500
Duan, Y., Yu, J., Chen, M., Lu, Q., Ning, F., Gan, X., Liu, H., Ye, Y., Lu, S., & Lash, G. E. (2023) · Figshare · doi:10.6084/m9.figshare.22679497
Additional file 2 of A patient-derived cell model for malignant transformation in IDH-mutant glioma
Kim, O., Sergi, Z., Yu, G., Yamamoto, K., Quezado, M., Abdullaev, Z., Crooks, D. R., Kishimoto, S., Li, Q., Lu, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981907
Additional file 1 of A patient-derived cell model for malignant transformation in IDH-mutant glioma
Kim, O., Sergi, Z., Yu, G., Yamamoto, K., Quezado, M., Abdullaev, Z., Crooks, D. R., Kishimoto, S., Li, Q., Lu, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981901
Duan, Y., Yu, J., Chen, M., Lu, Q., Ning, F., Gan, X., Liu, H., Ye, Y., Lu, S., & Lash, G. E. (2023) · Figshare · doi:10.6084/m9.figshare.22679488
Duan, Y., Yu, J., Chen, M., Lu, Q., Ning, F., Gan, X., Liu, H., Ye, Y., Lu, S., & Lash, G. E. (2023) · Figshare · doi:10.6084/m9.figshare.22679491
Rybacki, K., Cha, E. N. Y., Deutsch, H. M., Gaudet, E., Ahsan, M. U., Xu, F., Chan, J., Li, M., Song, Y., & Wang, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.13.711117
Presence of IDH2 and TP53 mutations significantly reduces survival of patients with chondrosarcoma
Weidlich, A., Schaser, K.-D., Juratli, T. A., Pablik, J., Märdian, S., Hauptmann, K., Schwabe, P., Richter, S., & Fritzsche, H. (2026) · Cancer · doi:10.1002/cncr.70376
Synthetic Lethality and Metabolism in Ewing Sarcoma : Knowledge Through Silence
Jonker, A. H. (2014) · theses.fr (ABES) · doi:10.70675/7e4efaeazcdf1z4e21zacfdza6f20813ef10 · Cited by 1
Characterization of cellular heterogeneity in Diffuse Low Grade Glioma
Augustus, M. (2020) · theses.fr (ABES) · doi:10.70675/037c23a4z44ddz4bb7z999ezb0c178c35170
Tu, Z., Hu, W., Zhang, J., Xing, Z., Li, J., Xu, J., Lin, M., Jiang, X., Cao, D., ZHANG, 张. J., et al. (2026) · Magnetic Resonance Letters · doi:10.1016/j.mrl.2026.200292
Role of isocitrate dehydrogenase enzyme in brain cancer, with a focus on glioma
Alkhalaileh, L., Essam, Z. M., Ibrahim, M. A., & Al-khalayleh, M. (2026) · Journal of King Saud University - Science · doi:10.25259/jksus_96_2026
Shahi, M., Virgin, K. L., Michaelides, L., Garcia, D. M., Basil, A. N., Quiñones‐Hinojosa, A., & Cooks, R. G. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2616216123
GLP1R agonists and vorasidenib converge on peroxynitrite-mediated cytotoxicity in mutant IDH gliomaPreprint
Taglang, C., Udutha, S., Phoenix, T. N., Lathia, J. D., de Groot, J., & Viswanath, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.18.759957
“We and others have demonstrated that D-2HG alters glucose, glutamine, nucleotide, redox, and phospholipid metabolism in mIDH glioma cells 15-19 .”
BindingDB (2016) · UC San Diego · doi:10.7270/q2w95800
Emerging Anti-cancer Targets in Mitochondria
Ježek, P., Smolková, K., Dvořák, A., & Olejár, T. (2014) · Springer eBooks · doi:10.1007/978-94-017-8984-4_10
The Dual Role of HIF Hydroxylase PHD3 in Cancer Cell Survival
Rantanen, K. (2012) · UTUPub (University of Turku)
Metadata
- Authors
- Reitman, Z. J., Jin, G., Karoly, E. D., Spasojevic, I., Yang, J., Kinzler, K. W., He, Y., Bigner, D. D., Vogelstein, B., & Yan, H.
- Affiliations
- Duke University (US)
- Metabolon (United States) (US)
- Duke Comprehensive Cancer Center,
- The Ludwig Center and
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-02-02
- Volume
- 108
- Issue
- 8
- Pages
- 3270-3275
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3044380
- OpenAlex
- W2171026968
- Cited by
- 449
- References
- 31
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 12 · 2023: 24 · 2022: 20 · 2021: 21 · 2020: 23 · 2019: 25 · 2018: 38 · 2017: 34 · 2016: 29 · 2015: 38 · 2014: 45 · 2013: 42 · 2012: 48
- FWCI
- 24.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- American Association for Cancer Research
- Pediatric Brain Tumor Foundation
- Virginia and D.K. Ludwig Fund for Cancer Research
- National Institutes of Health
- National Cancer Institute (CA43460, 5P30-CA-014236-36, R37CA043460, R01CA140316, P30CA014236)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- isocitrate dehydrogenase, IDH1 mutation, IDH2 mutation, 2-hydroxyglutarate, glioma, oligodendroglioma, N-acetylaspartylglutamate, glutathione metabolism, choline derivatives, TCA cycle intermediates, amino acids, cancer metabolism
- MeSH terms
- Dipeptides, Glioma, Glutarates, Humans, Isocitrate Dehydrogenase, Mutation, Oligodendroglioma, Cell Line, Tumor, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
